Defibrotide for the treatment of veno-occlusive disease after liver transplantation

Transplantation

Volumn 72, Issue 7, 2001, Pages 1237-1240

  Mor, Eytan ^a,b   Pappo, Orit ^a,b   Bar Nathan, Nathan ^a,b   Shaharabani, Ezra ^a,b   Shapira, Zaki ^a,b   Tur Kaspa, Ran ^a,b   Ben Ari, Ziv ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; BILIRUBIN; DEFIBROTIDE; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ASCITES; BLOOD CLOT LYSIS; CASE REPORT; DISEASE ASSOCIATION; ESCHERICHIA COLI; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER NECROSIS; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; TREATMENT OUTCOME; VEIN OCCLUSION; WEIGHT GAIN;

EID: 0035886247     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110150-00009     Document Type: Article

References (25)

1. Veno-occlusive disease of the liver with non-portal type of cirrhosis, occurring in Jamaica
2. Hepatic veno-occlusive disease
3. An epidemic veno-occlusive disease of liver in central India
4. Pathogenesis of veno-occlusive liver disease after radiation
5. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence and predisposing factors
6. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy
7. Azathioprine hepatotoxicity after liver transplantation
8. Hepatic venular stenosis after orthotopic liver transplantation
9. "Silent" presentation of venoocclusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection
10. Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation
11. Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients
12. Defibrotide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders
13. Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro
14. Defibrotide
15. Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man
16. Antithrombotic effect and clinical potential of defibrotide
17. Treatment of severe venoocclusive disease with defibrotide: Compassionate-use results in response without significant toxicity in a high-risk population
18. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
19. Side-to-side cavo-cavostomy: A useful aid in "complicated" piggyback liver transplantation
20. Hepatic outflow study after piggyback liver transplantation
21. Analysis of the complications of the piggy-back technique in 1,112 liver transplants
22. Antithrombin III (AT3) treatment of organ dysfunction during bone marrow transplantation (BMT): Results of a pilot study
23. 1
24. Transjugular intrahepatic portosystemic shunt after adult liver transplantation
25. Orthotopic liver transplantation for life-threatening veno-occlusive disase of the liver after allogenic bone marrow transplant